Statistics for MALDI-TOF MS-based urinary proteomic/peptidomic signature of breast cancer as innovative diagnostic approach
Total visits
| views | |
|---|---|
| MALDI-TOF MS-based urinary proteomic/peptidomic signature of breast cancer as innovative diagnostic approach | 193 |
Total visits per month
| views | |
|---|---|
| April 2025 | 0 |
| May 2025 | 1 |
| June 2025 | 0 |
| July 2025 | 0 |
| August 2025 | 0 |
| September 2025 | 2 |
| October 2025 | 0 |
File Visits
| views | |
|---|---|
| Relatório.pdf | 58 |
Top country views
| views | |
|---|---|
| Germany | 70 |
| Ukraine | 47 |
| United Kingdom | 21 |
| Portugal | 18 |
| United States | 16 |
| Israel | 4 |
| Brazil | 3 |
| Iran | 2 |
| Japan | 2 |
| Austria | 1 |
| China | 1 |
| Ireland | 1 |
| Italy | 1 |
| South Korea | 1 |
| Luxembourg | 1 |
| Malaysia | 1 |
| Pakistan | 1 |
| Qatar | 1 |
| Saudi Arabia | 1 |
Top city views
| views | |
|---|---|
| Luxembourg | 1 |